Phase 2 trial reveals potential of DPP-1 inhibitor for bronchiectasis
The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...
Real-time analysis reveals a much higher proportion of harmful substances in particulate matter than assumed
People breathing contaminated air over the course of years are at greater risk of developing numerous diseases. This is ...